Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy

被引：0

作者：

Ghaly, Simon ^{[1
,2
]}

Gill, Raghubinder S. ^{[3
]}

Keegan, Mathew J. ^{[3
]}

Angus, Peter W. ^{[4
]}

George, Jacob ^{[5
,6
]}

Nicoll, Amanda J. ^{[7
]}

Law, Matthew ^{[8
]}

Sinclair, Marie ^{[9
]}

Lim, Lucy Y. ^{[4
]}

Ratnayake, Hasanka ^{[7
]}

Dunn, Anna ^{[7
]}

Strasser, Simone I. ^{[3
]}

Zekry, Amany ^{[1
,2
]}

机构：

[1] St George Hosp, Sydney, NSW, Australia

[2] St George Hosp, Sydney, NSW, Australia

[3] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia

[4] Austin Hosp, Gastroenterol & Liver Transplant Unit, Melbourne, Vic 3084, Australia

[5] Westmead Hosp, Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia

[6] Univ Sydney, Sydney, NSW 2006, Australia

[7] Royal Melbourne Hosp, Melbourne, Vic, Australia

[8] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia

[9] Monash Med Ctr, Melbourne, Vic, Australia

来源：

HEPATOLOGY | 2012年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

332

引用

下载

页码：354A / 354A

页数：1

共 50 条

[21] Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B
Koklu, Seyfettin
TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (01): : 124 - 124
[22] Can antiviral therapy in patients with chronic hepatitis B prevent the development of hepatocellular carcinoma?
Vasilieva, L.
Dourakis, S. P.
ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (05): : 566 - 575
[23] Performance of fibrosis biomarkers for stratifying hepatocellular carcinoma risk in patients under antiviral therapy for chronic hepatitis B
Lee, Sang-geul
Song, Byeong Geun
Sinn, Dong Hyun
Kang, Won-seok
Gwak, Geum-Youn
Paik, Yong-Han
Choi, Moon Seok
Lee, Joon Hyeok
Koh, Kwang Cheol
Paik, Seung Woon
HEPATOLOGY, 2017, 66 : 1014A - 1014A
[24] Risk prediction models for hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy: A meta-analysis
Shen, Yueli
Liu, Jiao
Han, Zhi
Jiang, Weiyun
Cui, Huaizhong
Xun, Yunhao
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (06)
[25] Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
Joo Hyun Oh
Hye Won Lee
Dong Hyun Sinn
Jun Yong Park
Beom Kyung Kim
Seung Up Kim
Do Young Kim
Sang Hoon Ahn
Wonseok Kang
Geum-Youn Gwak
Moon Seok Choi
Joon Hyeok Lee
Kwang Cheol Koh
Seung Woon Paik
Yong-Han Paik
Hepatology International, 2021, 15 : 892 - 900
[26] Risk of Hepatocellular Carcinoma Decreases over Time in Chronic Hepatitis B Patients on Antiviral Therapy with Entecavir or Tenofovir
Hsu, Yao-Chun
Ho, Hsiu-Jon
El-Serag, Hashem B.
Lin, Jaw-Town
Wu, Chun-Ying
HEPATOLOGY, 2016, 64 : 56A - 56A
[27] Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients
Tamaki, Nobuharu
Kurosaki, Masayuki
Kirino, Sakura
Izumi, Namiki
HEPATOLOGY RESEARCH, 2021, 51 (11) : 1170 - 1171
[28] Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
Oh, Joo Hyun
Lee, Hye Won
Sinn, Dong Hyun
Park, Jun Yong
Kim, Beom Kyung
Kim, Seung Up
Kim, Do Young
Ahn, Sang Hoon
Kang, Wonseok
Gwak, Geum-Youn
Choi, Moon Seok
Lee, Joon Hyeok
Koh, Kwang Cheol
Paik, Seung Woon
Paik, Yong-Han
HEPATOLOGY INTERNATIONAL, 2021, 15 (04) : 892 - 900
[29] Reduction of Cirrhosis and Hepatocellular Carcinoma With Antiviral Therapy in Chronic Hepatitis B
Liaw, Yun-Fan
HEPATOLOGY, 2013, 58 (05) : 1856 - 1856
[30] Long-Term Assessment of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients With Sustained Viral Response to Antiviral Therapy
Wang, Chun-Hsiang
Chang, Kuo-Kwen
GASTROENTEROLOGY, 2012, 142 (05) : S958 - S958

← 1 2 3 4 5 →